Please enable JavaScript to continue using this application.

Compare $IMUX vs $XGN | Chartloom

Compare

$IMUX vs $XGN

Immunic Inc · Exagen Inc

IMUX

Immunic Inc

XGN

Exagen Inc

Compare $IMUX vs $XGN

Comparing Immunic Inc and Exagen Inc

IMUXImmunic Inc

XGNExagen Inc

IMUXImmunic Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

40.5%

52W performance

-8.8%

FCF yield

-78.9%

XGNExagen Inc

Market cap

$203M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.63x

Rev growth (TTM)

20.8%

YTD performance

39.4%

52W performance

-23.3%

FCF yield

-3.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMUX

XGN

Detailed metrics comparison

IMUX

Immunic Inc

XGN

Exagen Inc

Market Cap

IMUX$112M

XGN$203M

Enterprise Value

IMUX$-44M

XGN$204M

Price

IMUX$8.19

XGN$8.42

P/E Ratio

IMUXN/A

XGNN/A

P/S Ratio

IMUX0.00x

XGN2.86x

EV/Sales

IMUX0.00x

XGN2.87x

EV/EBITDA

IMUX0.00x

XGN0.00x

P/B Ratio

IMUX0.85x

XGN16.60x

P/FCF Ratio

IMUXN/A

XGNN/A

EV/FCF

IMUX0.49x

XGN-26.94x

PEG Ratio

IMUXN/A

XGNN/A

Forward P/E (NTM)

IMUXN/A

XGNN/A

Forward P/S (NTM)

IMUXN/A

XGN2.63x

Revenue (TTM)

IMUX$0

XGN$71M

Revenue Growth (YoY)

IMUXN/A

XGN20.8%

Forward Rev Growth

IMUX650.4%

XGN10.1%

Gross Margin (TTM)

IMUX0.0%

XGN58.6%

Operating Margin (TTM)

IMUX0.0%

XGN0.0%

EBITDA Margin (TTM)

IMUX0.0%

XGN-15.1%

Net Margin (TTM)

IMUX0.0%

XGN-26.6%

FCF Margin (TTM)

IMUXN/A

XGN-10.7%

Net Income (TTM)

IMUX$-112M

XGN$-19M

FCF (TTM)

IMUX$-88M

XGN$-8M

EPS (TTM)

IMUX-$2.62

XGN-$0.78

ROE (TTM)

IMUX-9567.0%

XGN-12162.0%

ROA (TTM)

IMUX-10788.0%

XGN-3368.0%

ROIC (TTM)

IMUX-9567.0%

XGN-4566.0%

Cash

IMUX$155M

XGN$25M

Debt

IMUX$0

XGN$26M

Net Cash/Debt

IMUX$155M

XGN$-959K

Current Ratio (TTM)

IMUX5.05x

XGN3.18x

Quick Ratio (TTM)

IMUX5.00x

XGN2.75x

Debt/Equity (TTM)

IMUX0.00x

XGN2.09x

Debt/Assets (TTM)

IMUX0.0%

XGN0.0%

Interest Coverage (TTM)

IMUXN/A

XGNN/A

Net Debt/EBITDA (TTM)

IMUX0.00x

XGN0.00x

Beta

IMUX1.47

XGN2.28

52W Performance

IMUX-8.8%

XGN-23.3%

YTD Performance

IMUX40.5%

XGN39.4%

% from 52W High

IMUX-53.0%

XGN-31.2%

% from 52W Low

IMUX61.9%

XGN225.1%

Asset Turnover (TTM)

IMUX0.00x

XGN1.27x

FCF Yield (TTM)

IMUX-78.9%

XGN-3.7%

Earnings Yield (TTM)

IMUX-100.0%

XGN-9.3%

Dividend Yield (TTM)

IMUXN/A

XGNN/A

Rule of 40

IMUX0.0

XGN10.2

EV/GP/RG

IMUXN/A

XGN0.55

Ticker research

View IMUX research View XGN research

Metric	IMUX Immunic Inc	XGN Exagen Inc
Market & Valuation
Market Cap	$112M	$203M
Enterprise Value	$-44M	$204M
Price	$8.19	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.86x
EV/Sales	0.00x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	0.49x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.63x
Revenue & Growth
Revenue (TTM)	$0	$71M
Revenue Growth (YoY)	N/A	20.8%
Forward Rev Growth	650.4%	10.1%
Profitability
Gross Margin (TTM)	0.0%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-15.1%
Net Margin (TTM)	0.0%	-26.6%
FCF Margin (TTM)	N/A	-10.7%
Net Income (TTM)	$-112M	$-19M
FCF (TTM)	$-88M	$-8M
EPS (TTM)	-$2.62	-$0.78
ROE (TTM)	-9567.0%	-12162.0%
ROA (TTM)	-10788.0%	-3368.0%
ROIC (TTM)	-9567.0%	-4566.0%
Financial Health
Cash	$155M	$25M
Debt	$0	$26M
Net Cash/Debt	$155M	$-959K
Current Ratio (TTM)	5.05x	3.18x
Quick Ratio (TTM)	5.00x	2.75x
Debt/Equity (TTM)	0.00x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.47	2.28
52W Performance	-8.8%	-23.3%
YTD Performance	40.5%	39.4%
% from 52W High	-53.0%	-31.2%
% from 52W Low	61.9%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.27x
FCF Yield (TTM)	-78.9%	-3.7%
Earnings Yield (TTM)	-100.0%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	10.2
EV/GP/RG	N/A	0.55
Ticker research	View IMUX research	View XGN research

Valuation

P/S Ratio

IMUX

0.00x

XGN

2.86x

EV/FCF

XGN

-26.94x

IMUX

0.49x

Growth & revenue

Revenue Growth TTM

XGN

20.8%

Forward Revenue Growth

IMUX

650.4%

XGN

10.1%

Profitability & performance

Gross Margin

XGN

58.6%

IMUX

0.0%

ROE

IMUX

-9567.0%

XGN

-12162.0%

FCF Yield %

XGN

-3.7%

IMUX

-78.9%

52-Week Performance

IMUX

-8.8%

XGN

-23.3%

Detailed metrics comparison

IMUX

Immunic Inc

XGN

Exagen Inc

Market Cap

IMUX$112M

XGN$203M

Enterprise Value

IMUX$-44M

XGN$204M

Price

IMUX$8.19

XGN$8.42

P/E Ratio

IMUXN/A

XGNN/A

P/S Ratio

IMUX0.00x

XGN2.86x

EV/Sales

IMUX0.00x

XGN2.87x

EV/EBITDA

IMUX0.00x

XGN0.00x

P/B Ratio

IMUX0.85x

XGN16.60x

P/FCF Ratio

IMUXN/A

XGNN/A

EV/FCF

IMUX0.49x

XGN-26.94x

PEG Ratio

IMUXN/A

XGNN/A

Forward P/E (NTM)

IMUXN/A

XGNN/A

Forward P/S (NTM)

IMUXN/A

XGN2.63x

Revenue (TTM)

IMUX$0

XGN$71M

Revenue Growth (YoY)

IMUXN/A

XGN20.8%

Forward Rev Growth

IMUX650.4%

XGN10.1%

Gross Margin (TTM)

IMUX0.0%

XGN58.6%

Operating Margin (TTM)

IMUX0.0%

XGN0.0%

EBITDA Margin (TTM)

IMUX0.0%

XGN-15.1%

Net Margin (TTM)

IMUX0.0%

XGN-26.6%

FCF Margin (TTM)

IMUXN/A

XGN-10.7%

Net Income (TTM)

IMUX$-112M

XGN$-19M

FCF (TTM)

IMUX$-88M

XGN$-8M

EPS (TTM)

IMUX-$2.62

XGN-$0.78

ROE (TTM)

IMUX-9567.0%

XGN-12162.0%

ROA (TTM)

IMUX-10788.0%

XGN-3368.0%

ROIC (TTM)

IMUX-9567.0%

XGN-4566.0%

Cash

IMUX$155M

XGN$25M

Debt

IMUX$0

XGN$26M

Net Cash/Debt

IMUX$155M

XGN$-959K

Current Ratio (TTM)

IMUX5.05x

XGN3.18x

Quick Ratio (TTM)

IMUX5.00x

XGN2.75x

Debt/Equity (TTM)

IMUX0.00x

XGN2.09x

Debt/Assets (TTM)

IMUX0.0%

XGN0.0%

Interest Coverage (TTM)

IMUXN/A

XGNN/A

Net Debt/EBITDA (TTM)

IMUX0.00x

XGN0.00x

Beta

IMUX1.47

XGN2.28

52W Performance

IMUX-8.8%

XGN-23.3%

YTD Performance

IMUX40.5%

XGN39.4%

% from 52W High

IMUX-53.0%

XGN-31.2%

% from 52W Low

IMUX61.9%

XGN225.1%

Asset Turnover (TTM)

IMUX0.00x

XGN1.27x

FCF Yield (TTM)

IMUX-78.9%

XGN-3.7%

Earnings Yield (TTM)

IMUX-100.0%

XGN-9.3%

Dividend Yield (TTM)

IMUXN/A

XGNN/A

Rule of 40

IMUX0.0

XGN10.2

EV/GP/RG

IMUXN/A

XGN0.55

Ticker research

View IMUX research View XGN research

Metric	IMUX Immunic Inc	XGN Exagen Inc
Market & Valuation
Market Cap	$112M	$203M
Enterprise Value	$-44M	$204M
Price	$8.19	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.86x
EV/Sales	0.00x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	0.49x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.63x
Revenue & Growth
Revenue (TTM)	$0	$71M
Revenue Growth (YoY)	N/A	20.8%
Forward Rev Growth	650.4%	10.1%
Profitability
Gross Margin (TTM)	0.0%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-15.1%
Net Margin (TTM)	0.0%	-26.6%
FCF Margin (TTM)	N/A	-10.7%
Net Income (TTM)	$-112M	$-19M
FCF (TTM)	$-88M	$-8M
EPS (TTM)	-$2.62	-$0.78
ROE (TTM)	-9567.0%	-12162.0%
ROA (TTM)	-10788.0%	-3368.0%
ROIC (TTM)	-9567.0%	-4566.0%
Financial Health
Cash	$155M	$25M
Debt	$0	$26M
Net Cash/Debt	$155M	$-959K
Current Ratio (TTM)	5.05x	3.18x
Quick Ratio (TTM)	5.00x	2.75x
Debt/Equity (TTM)	0.00x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.47	2.28
52W Performance	-8.8%	-23.3%
YTD Performance	40.5%	39.4%
% from 52W High	-53.0%	-31.2%
% from 52W Low	61.9%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.27x
FCF Yield (TTM)	-78.9%	-3.7%
Earnings Yield (TTM)	-100.0%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	10.2
EV/GP/RG	N/A	0.55
Ticker research	View IMUX research	View XGN research